Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Response and Toxicity to the Second Course of 3 Cycles of 177Lu-PSMA Therapy Every 4 Weeks in Patients with Metastatic Castration-Resistant Prostate Cancer.
Rasul S, Wollenweber T, Zisser L, Kretschmer-Chott E, Grubmüller B, Kramer G, Shariat SF, Eidherr H, Mitterhauser M, Vraka C, Langsteger W, Hacker M, Haug AR. Rasul S, et al. Cancers (Basel). 2021 May 20;13(10):2489. doi: 10.3390/cancers13102489. Cancers (Basel). 2021. PMID: 34065303 Free PMC article.
In Vivo Quantification of Myocardial Amyloid Deposits in Patients with Suspected Transthyretin-Related Amyloidosis (ATTR).
Wollenweber T, Rettl R, Kretschmer-Chott E, Rasul S, Kulterer O, Rainer E, Raidl M, Schaffarich MP, Matschitsch S, Stadler M, Traub-Weidinger T, Beiztke D, Loewe C, Duca F, Mascherbauer J, Bonderman D, Hacker M. Wollenweber T, et al. J Clin Med. 2020 Oct 27;9(11):3446. doi: 10.3390/jcm9113446. J Clin Med. 2020. PMID: 33120935 Free PMC article.
Prediction of response and survival after standardized treatment with 7400 MBq 177Lu-PSMA-617 every 4 weeks in patients with metastatic castration-resistant prostate cancer.
Rasul S, Hartenbach M, Wollenweber T, Kretschmer-Chott E, Grubmüller B, Kramer G, Shariat S, Wadsak W, Mitterhauser M, Pichler V, Vraka C, Hacker M, Haug AR. Rasul S, et al. Eur J Nucl Med Mol Imaging. 2021 May;48(5):1650-1657. doi: 10.1007/s00259-020-05082-5. Epub 2020 Oct 30. Eur J Nucl Med Mol Imaging. 2021. PMID: 33128131 Free PMC article.
Management of adrenocortical carcinoma: are we making progress?
Kiesewetter B, Riss P, Scheuba C, Mazal P, Kretschmer-Chott E, Haug A, Raderer M. Kiesewetter B, et al. Ther Adv Med Oncol. 2021 Aug 31;13:17588359211038409. doi: 10.1177/17588359211038409. eCollection 2021. Ther Adv Med Oncol. 2021. PMID: 34484430 Free PMC article. Review.
Renal and Salivary Gland Functions after Three Cycles of PSMA-617 Therapy Every Four Weeks in Patients with Metastatic Castration-Resistant Prostate Cancer.
Wollenweber T, Zisser L, Kretschmer-Chott E, Weber M, Grubmüller B, Kramer G, Shariat SF, Mitterhauser M, Schmitl S, Vraka C, Haug AR, Hacker M, Hartenbach M, Rasul S. Wollenweber T, et al. Among authors: kretschmer chott e. Curr Oncol. 2021 Sep 23;28(5):3692-3704. doi: 10.3390/curroncol28050315. Curr Oncol. 2021. PMID: 34590608 Free PMC article.
Does [99mTc]-3,3-diphosphono-1,2-propanodicarboxylic acid (DPD) soft tissue uptake allow the identification of patients with the diagnosis of cardiac transthyretin-related (ATTR) amyloidosis with higher risk for polyneuropathy?
Wollenweber T, Kretschmer-Chott E, Wurm R, Rasul S, Kulterer O, Rettl R, Duca F, Bonderman D, Sühs KW, Hacker M, Traub-Weidinger T. Wollenweber T, et al. Among authors: kretschmer chott e. J Nucl Cardiol. 2023 Feb;30(1):357-367. doi: 10.1007/s12350-022-02986-7. Epub 2022 Jul 11. J Nucl Cardiol. 2023. PMID: 35817943 Free PMC article.
Response to [ 177 Lu]Lu-PSMA radioligand therapy in metastatic castration-resistant prostate cancer patients presenting with only lymph node metastases.
Zisser L, Yu J, Oszwald A, Wollenweber T, Kretschmer-Chott E, Grubmüller B, Kramer G, Shariat SF, Mitterhauser M, Vraka C, Hacker M, Haug AR, Rasul S. Zisser L, et al. Among authors: kretschmer chott e. Nucl Med Commun. 2022 Nov 1;43(11):1113-1120. doi: 10.1097/MNM.0000000000001611. Epub 2022 Sep 19. Nucl Med Commun. 2022. PMID: 36120814 Free PMC article.
Treatment patterns and oncological outcome of patients with advanced small intestinal neuroendocrine tumors: real-world data from the Medical University of Vienna.
Melhorn P, Kretschmer-Chott E, Wolff L, Haug A, Mazal P, Raderer M, Kiesewetter B. Melhorn P, et al. Among authors: kretschmer chott e. Ther Adv Med Oncol. 2022 Nov 19;14:17588359221138389. doi: 10.1177/17588359221138389. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 36425874 Free PMC article.
16 results